Are they ready to maximize the value of pharmaceuticals in patient care?
NPC at a Glance
NPC is a health policy research organization focused on the critical issues of evidence, the value of medicines for patients, and innovation...more
CER
Do stakeholders think comparative effectiveness research is having an impact on health care decision making? Which organizations are viewed as the leaders on prioritizing, funding, and conducting research? Download our new booklet to find out...more
Value of Rx
Recent NPC research has focused on defining the optimal role and value of pharmaceuticals in the evolving payment and delivery models...more
Individual Treatment Effects
Being "unique" can impact your health care treatments. Learn more about the challenges of individual treatment effects...more
NPC VIDEO
RECENT NEWS
#TBT: Making Informed Decisions: What Kinds of Studies Will PCORnet Undertake?
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... moreCER Tweets of the Week (April 14-18, 2014)
This week, health care stakeholders highlighted both future and past events focused on comparative effectiveness... moreCER Tweets of the Week (April 7-11, 2014)
Collaboration was a popular topic among comparative effectiveness research (CER) stakeholders on Twitter this... more
Webinar: CER Collaborative: Tools You Can Use
Collaborative members hosted a webinar explaining how to use the tools they developed to create greater... more
AHRQ’s EHC Program Compares Cancer Survivorship Care Models
Did you know that the number of cancer survivors in the United States is projected to grow to 18 million by 2020... moreCMS Halts Plan to Remove Protected Classes and Limit Patient Access to Medications
It was a win for patients and individualized care. On March 11, Centers for Medicare and Medicaid Services (CMS... moreMedication Adherence Lessons Under VBID
A new study identifies five key features of value-based insurance design (VBID) plans that are associated with... morePCORI News Round Up: AHRQ’s Slutsky Appointed, Board Approves McNamara and Dueñas
On March 18, the Patient-Centered Outcomes Research Institute (PCORI) named Jean Slutsky, PA, MSPH as its chief... more
CER Collaborative Improving Health Outcomes Through New Comparative Evidence Tools
(Washington, DC, March 24, 2014)—Three peer-reviewed articles published in Value in Health offer important... moreNPC, Quintiles Study Tests Tools to Evaluate Quality of Observational Research in Comparative Effectiveness Studies
(Washington, DC, February 25, 2014)—With the growing demand for information about comparative effectiveness and... moreEli Lilly and Company Joins the National Pharmaceutical Council
Washington, D.C. (January 22, 2014)—The National Pharmaceutical Council (NPC) today announced that Eli Lilly and... moreNew Peer-Reviewed Study Shows Mixed Results in ACO Medication Readiness To Achieve Quality, Cost Goals
Washington, D.C.—As Accountable Care Organizations (ACOs) gain traction among both private and public payers, so... more
Healthcare Leadership Council & NPC Submit Comments to CMS on Access to Part D Data
March 7, 2014The Honorable Marilyn Tavenner, AdministratorCenters for Medicare & Medicaid ServicesU.S.... moreNPC Comments on CMS' Proposed Changes to Protected Classes
March 7, 2014Marilyn B. TavennerAdministratorCenters for Medicare & Medicaid ServicesU.S. Department of... moreThe State of CER and the Environment for Health Care Decision Making
This month, NPC released its third annual survey on stakeholders’ views on comparative effectiveness research (... moreKeeping Our Eye on the CER Ball
Until the cherry blossoms begin to bloom later next month, most of the water cooler conversations in Washington... moreWebinar: CER Collaborative: Tools You Can Use
Collaborative members hosted a webinar explaining how to use the tools they developed to create greater... moreIMEDS: Sentinel and OMOP Programs
Jane Reese-Coulbourne, MS, ChE, executive director of the Reagan-Udall Foundation, talks about the Food and Drug... moreBig Data: Its Evolving Use and Challenges
William Crown, PhD, chief scientific officer at Optum Labs, discusses how the use and nature of big data in... moreUse of Big and Real-World Data by Pharma: More than Data Warehousing
Real-world data—a subset of big data—is clinical data used for decision-making that did not come from a clinical... more#TBT: Making Informed Decisions: What Kinds of Studies Will PCORnet Undertake?
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... moreCER Tweets of the Week (April 14-18, 2014)
This week, health care stakeholders highlighted both future and past events focused on comparative effectiveness... moreCER Tweets of the Week (April 7-11, 2014)
Collaboration was a popular topic among comparative effectiveness research (CER) stakeholders on Twitter this... more#TBT: Medicaid Expansion & Historical Data
As part of our “Throwback Thursday” blog series, we’re taking a look at a topic that’s currently in the news and... moreNEWS FEEDS
EVENT
Second National Health Insurance Exchange Summit
Join NPC Chief Science Officer Dr. Robert Dubois as he leads a discussion about how pharmaceutical and medical device companies will participate in health insurance exchanges.
May 15, 2014
2:15 pm
Capital Hilton
Washington, DC
NEWS
NPC, Quintiles Study Tests Tools to Evaluate Quality of Observational Research in Comparative Effectiveness Studies
The GRACE checklist contains 11 items about data and research methods that can be used as an initial screening tool to separate observational studies that meet baseline quality criteria from those that do not.